All lobbying filings

CROSSROADS STRATEGIES, LLC

Lobbying for VERTEX PHARMACEUTICALS INCORPORATED · biopharmaceutical company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · Massachusetts · House · Senate · $50,000.00 income · posted Jul 17, 2026

Official filing document

Bills named in this filing 2

S 475
Alternatives to PAIN Act
HR 1227
Alternatives to PAIN Act

Lobbying activity 4

Health Issues

General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Education about non-opioid pain therapies.H.R.1227/S.475 Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act.

Medical/Disease Research/Clinical Labs

General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Education about precision medicine.

Medicare/Medicaid

General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Education about the importance of access to non-opioid pain therapies for Medicare beneficiaries. H.R.1227/S.475 Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act.

Trade (domestic/foreign)

Policies impacting the manufacturing pharmaceutical products including tariffs.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.